mRNA |
NVP-231 |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.01 |
mRNA |
MLN4924 |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.01 |
mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.01 |
mRNA |
Ki8751 |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.01 |
mRNA |
ML006 |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.01 |
mRNA |
FQI-1 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.01 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.01 |
mRNA |
necrosulfonamide |
CTRPv2 |
pan-cancer |
AAC |
0.098 |
0.01 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.01 |
mRNA |
Teniposide |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.02 |